search
Back to results

Cardiovascular Responses to Spartathlon Running (Spartathlon)

Primary Purpose

Disorder Heart

Status
Completed
Phase
Not Applicable
Locations
Greece
Study Type
Interventional
Intervention
246-km running
Sponsored by
Aristotle University Of Thessaloniki
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional screening trial for Disorder Heart

Eligibility Criteria

18 Years - 67 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Runners at least 18 years old, healthy and sufficiently trained.
  • Runners being accepted to participate in the Spartathlon race according to the eligibility criteria (http://www.spartathlon.gr/en/registration-en.html)
  • Runners who will volunteer to be examined pre- and post the race

Exclusion Criteria:

  • Runners with chronic diseases
  • Runners receiving any medication

Sites / Locations

  • Laboratory of Sports Medicine

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Athletes

Arm Description

246-km running

Outcomes

Primary Outcome Measures

Change of right ventricular function after one day ultra-marathon running
Echocardiographic study of left ventricular function

Secondary Outcome Measures

Change of left ventricular function after one day ultra-marathon running
Echocardiographic study of left ventricular function
Change of carotid artery function after one day ultra-marathon running
Echocardiographic study of carotid arteries

Full Information

First Posted
September 28, 2017
Last Updated
July 19, 2023
Sponsor
Aristotle University Of Thessaloniki
search

1. Study Identification

Unique Protocol Identification Number
NCT03304483
Brief Title
Cardiovascular Responses to Spartathlon Running
Acronym
Spartathlon
Official Title
Cardiovascular Effects of Ultramarathon Running
Study Type
Interventional

2. Study Status

Record Verification Date
July 2023
Overall Recruitment Status
Completed
Study Start Date
September 29, 2017 (Actual)
Primary Completion Date
December 30, 2019 (Actual)
Study Completion Date
June 30, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Aristotle University Of Thessaloniki

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
The aim of this study is to examine the cardiovascular effects of ultramarathon running and their relation to performance.
Detailed Description
The purpose of the study is to determine the changes of cardiovascular morphology and function after an ultramarathon race. 50 entrants to the "Spartathlon 2017" 246-km running race will participate in the study. Cardiac and arterial morphology and function tests will be conducted one day before the race and within 20 minutes of race completion.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Disorder Heart

7. Study Design

Primary Purpose
Screening
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
athletes participating in the ultra marathon running
Masking
None (Open Label)
Masking Description
Before and after the race
Allocation
N/A
Enrollment
50 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Athletes
Arm Type
Experimental
Arm Description
246-km running
Intervention Type
Other
Intervention Name(s)
246-km running
Intervention Description
Spartathlon 2017
Primary Outcome Measure Information:
Title
Change of right ventricular function after one day ultra-marathon running
Description
Echocardiographic study of left ventricular function
Time Frame
before and after 1 day running
Secondary Outcome Measure Information:
Title
Change of left ventricular function after one day ultra-marathon running
Description
Echocardiographic study of left ventricular function
Time Frame
before and after 1 day running
Title
Change of carotid artery function after one day ultra-marathon running
Description
Echocardiographic study of carotid arteries
Time Frame
before and after 1 day running

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
67 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Runners at least 18 years old, healthy and sufficiently trained. Runners being accepted to participate in the Spartathlon race according to the eligibility criteria (http://www.spartathlon.gr/en/registration-en.html) Runners who will volunteer to be examined pre- and post the race Exclusion Criteria: Runners with chronic diseases Runners receiving any medication
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Evangelia Kouidi, Professor
Organizational Affiliation
Aristotle University of Thessaloniki, Greece
Official's Role
Principal Investigator
Facility Information:
Facility Name
Laboratory of Sports Medicine
City
Thessaloniki
ZIP/Postal Code
546 35
Country
Greece

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
No personal details will be shared. Only the results of the measurements will be available
Citations:
PubMed Identifier
17219787
Citation
Seedhouse EL, Walsh ML, Blaber AP. Heart rate, mean arterial blood pressure, and pulmonary function changes associated with an ultraendurance triathlon. Wilderness Environ Med. 2006 Winter;17(4):240-5. doi: 10.1580/pr27-05-r1.1.
Results Reference
background
PubMed Identifier
22812424
Citation
Millet GP, Millet GY. Ultramarathon is an outstanding model for the study of adaptive responses to extreme load and stress. BMC Med. 2012 Jul 19;10:77. doi: 10.1186/1741-7015-10-77.
Results Reference
background
PubMed Identifier
25010150
Citation
Cote AT, Phillips AA, Foulds HJ, Charlesworth SA, Bredin SS, Burr JF, Koehle MS, Warburton DE. Sex differences in cardiac function after prolonged strenuous exercise. Clin J Sport Med. 2015 May;25(3):276-83. doi: 10.1097/JSM.0000000000000130.
Results Reference
background
PubMed Identifier
23685440
Citation
Jee H, Park J, Oh JG, Lee YH, Shin KA, Kim YJ. Effect of a prolonged endurance marathon on vascular endothelial and inflammation markers in runners with exercise-induced hypertension. Am J Phys Med Rehabil. 2013 Jun;92(6):513-22. doi: 10.1097/PHM.0b013e31829232db.
Results Reference
background
PubMed Identifier
15507692
Citation
Blaber AP, Walsh ML, Carter JB, Seedhouse EL, Walker VE. Cardiopulmonary physiology and responses of ultramarathon athletes to prolonged exercise. Can J Appl Physiol. 2004 Oct;29(5):544-63. doi: 10.1139/h04-035.
Results Reference
result

Learn more about this trial

Cardiovascular Responses to Spartathlon Running

We'll reach out to this number within 24 hrs